Davies Philip D sold $650K of VICR

Davies Philip D (Corp. VP-Global Sales & Mktg.) sold 3,072 shares of VICOR CORP (VICR) at an average of $211.69 ($200.06–$216.04, $0.65M total) across 9 trades on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Davies Philip D
Published Aug 5, 2026, 3:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 5, 2026, 3:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

Traders may monitor for patterns in insider activity, but this specific disclosure does not introduce new guidance, contracts, litigation, or operational changes.

02

Market read

A disclosed insider sale of roughly $650K in VICR, dated 2026-08-03 and filed 2026-08-05, with no accompanying company-specific catalyst.

03

What to watch

The net effect depends on whether there are offsetting insider buys or other contemporaneous disclosures, which are not provided in this article.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-05, transaction dated 2026-08-03

Background

The article is an SEC Form 4 insider transaction for ViCOR Corp, reporting an officer’s open-market sale executed under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

ViCOR Corp insider Davies Philip D sold about $650.3K of VICR shares via an open-market sale under a pre-arranged 10b5-1 plan.

Expected impact

Near-term impact is likely limited; any reaction would be sentiment-driven and typically fades as 10b5-1 sales are expected.

Evidence & confidence

The filing is a Form 4 insider transaction, explicitly tied to a pre-arranged 10b5-1 plan, and provides no new company-specific news beyond the sale details.

Market effects

No clear sector read-through from a single 10b5-1 insider sale.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification or tax planning and may not reflect bearish expectations, especially when executed under a 10b5-1 plan.

Key entities

  • VICOR CORP

    Company whose insider transaction is disclosed on SEC Form 4.

  • Davies Philip D

    Corp. VP-Global Sales & Mktg., officer/director who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VICRMed

VICR SWOT Analysis: Strong Revenue Growth and Patent Settlement

Vicor Corp (VICR) reported Q3 2026 revenue of $197.1M, up 78.5% YoY, driven by product sales and royalty revenue. Gross margin increased to 68.3%. The company has a strong order backlog of $406M but faces valuation concerns and customer concentration risks. It has growth opportunities in EVs and renewable energy. VICR's GF Score is 82/100, with high growth and profitability ratings but low valuation.

$VICRHigh

VICR Stock Surges On Blowout Q3 And Aggressive Capacity Bet

Vicor Corporation (VICR) stock rose 12.95% after reporting Q3 2026 revenue of $197.1M, up 78.5% YoY, with gross margin at 68.3%. The company's backlog and operating cash flow increased, driven by AI and high-performance systems demand. VICR is expanding capacity and faces an ITC investigation. Analysts raised price targets to $350-$360.

$VICRHighAI 8/10

Why is Vicor stock climbing today?

Vicor Corporation (VICR) stock rose 2.6% in morning trading, extending gains after its Q3 2026 earnings beat expectations. Revenue was $197.1M, up 78.5% YoY, with adjusted EPS of $1.33. Gross margin expanded to 68.3%, and the order backlog grew 166% YoY to $406M. Analysts maintained Buy ratings with price targets of $350 and $375. The stock traded at $209.36, above its 52-week low of $79 but below its high of $382.65.